指南与共识主动脉外科

胸主动脉腔内修复术在急慢性胸主动脉疾病中的应用:专家共识解读

Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ES
指南 / 共识 · Eur J Cardiothorac Surg · 2021-01-01

该专家共识由ESC心血管外科工作组、主动脉与外周血管疾病工作组及EAPCI联合制定,系统总结了TEVAR在急慢性胸主动脉疾病中的现有证据与推荐。文件强调主动脉中心化建设与心脏团队模式的重要性,提出改良术语与报告标准,并指出主动脉根部及急性A型夹层是未来主要挑战。

要点

  • TEVAR已成为多种急慢性胸主动脉疾病的标准治疗,但晚期失败需开放手术补救。
  • 建议参照心脏团队模式建立主动脉中心并集中化诊疗,以改善预后。
  • 主动脉根部尤其是急性A型夹层是未来需重点探索的领域。

核心结论

  • TEVAR已成为多种急慢性胸主动脉疾病的标准治疗,但需与开放手术统筹管理。
  • 主动脉中心化建设和集中化诊疗有助于持续改进技术并改善结局。
  • 主动脉根部尤其是急性A型主动脉夹层是未来数年的主要挑战。

研究设计与样本

  • 欧洲心脏病学会心血管外科工作组、主动脉与外周血管疾病工作组及EAPCI联合发布的专家共识文件。

主要发现

  • TEVAR自九十年代末临床应用以来已被广泛接受,并推动开放手术持续演变。
  • 晚期TEVAR失败需开放手术矫正,凸显两种治疗方式统一管理的必要性。

关键数值与推荐

  • 文件提供关于急慢性胸主动脉疾病中使用或不使用TEVAR的当前证据概要。
  • 文件分享改良术语和报告标准的最新推荐。

临床怎么用

  • 临床中应将TEVAR与开放手术纳入统一的主动脉中心管理体系。
  • 参照心脏团队模式建立主动脉中心并集中化诊疗以改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since its clinical implementation in the late nineties, thoracic endovascular aortic repair (TEVAR) has become the standard treatment of several acute and chronic diseases of the thoracic aorta. While TEVAR has been embraced by many, this disruptive technology has also stimulated the continuing evolution of open surgery, which became even more important as late TEVAR failures do need open surgical correction justifying the need to unite both treatment options under one umbrella. This fact shows the importance of-in analogy to the heart team-aortic centre formation and centralization of care, which stimulates continuing development and improves outcome . The next frontier to be explored is the most proximal component of the aorta-the aortic root, in particular in acute type A aortic dissection-which remains the main challenge for the years to come. The aim of this document is to provide the reader with a synopsis of current evidence regarding the use or non-use of TEVAR in acute and chronic thoracic aortic disease, to share latest recommendations for a modified terminology and for reporting standards and finally to provide a glimpse into future developments.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Czerny M, Pacini D, Aboyans V, et al. Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2021. PMID: 33011773. doi:10.1093/ejcts/ezaa268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。